Prelude Therapeutics Incorporated (PRLD)
NASDAQ·Healthcare·Biotechnology
$4.29
-5.20%
Mkt Cap $170.52M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$6.25
Range $3.00 – $10.00
Implied Upside
+45.9%
Consensus $6.25 vs current $4.29
NASDAQ·Healthcare·Biotechnology
$4.29
-5.20%
Mkt Cap $170.52M
No recent rating data.
Price Target (5 analysts)
$6.25
Range $3.00 – $10.00
+45.9%
Consensus $6.25 vs current $4.29